These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Protein aggregation in Alzheimer's disease: Aβ and τ and their potential roles in the pathogenesis of AD. Thal DR; Fändrich M Acta Neuropathol; 2015 Feb; 129(2):163-5. PubMed ID: 25600324 [No Abstract] [Full Text] [Related]
5. Combinatorial model of amyloid β and tau reveals synergy between amyloid deposits and tangle formation. Koller EJ; Ibanez KR; Vo Q; McFarland KN; Gonzalez De La Cruz E; Zobel L; Williams T; Xu G; Ryu D; Patel P; Giasson BI; Prokop S; Chakrabarty P Neuropathol Appl Neurobiol; 2022 Feb; 48(2):e12779. PubMed ID: 34825397 [TBL] [Abstract][Full Text] [Related]
6. Multicellular hypothesis for the pathogenesis of Alzheimer's disease. Goetzl EJ; Miller BL FASEB J; 2017 May; 31(5):1792-1795. PubMed ID: 28100644 [TBL] [Abstract][Full Text] [Related]
7. Review on Alzheimer's disease: Inhibition of amyloid beta and tau tangle formation. Ashrafian H; Zadeh EH; Khan RH Int J Biol Macromol; 2021 Jan; 167():382-394. PubMed ID: 33278431 [TBL] [Abstract][Full Text] [Related]
9. Dissecting phenotypic traits linked to human resilience to Alzheimer's pathology. Perez-Nievas BG; Stein TD; Tai HC; Dols-Icardo O; Scotton TC; Barroeta-Espar I; Fernandez-Carballo L; de Munain EL; Perez J; Marquie M; Serrano-Pozo A; Frosch MP; Lowe V; Parisi JE; Petersen RC; Ikonomovic MD; López OL; Klunk W; Hyman BT; Gómez-Isla T Brain; 2013 Aug; 136(Pt 8):2510-26. PubMed ID: 23824488 [TBL] [Abstract][Full Text] [Related]
10. A{beta} accelerates the spatiotemporal progression of tau pathology and augments tau amyloidosis in an Alzheimer mouse model. Hurtado DE; Molina-Porcel L; Iba M; Aboagye AK; Paul SM; Trojanowski JQ; Lee VM Am J Pathol; 2010 Oct; 177(4):1977-88. PubMed ID: 20802182 [TBL] [Abstract][Full Text] [Related]
11. Glycosaminoglycans and beta-amyloid, prion and tau peptides in neurodegenerative diseases. Díaz-Nido J; Wandosell F; Avila J Peptides; 2002 Jul; 23(7):1323-32. PubMed ID: 12128089 [TBL] [Abstract][Full Text] [Related]
12. Amyloid-β and tau: the trigger and bullet in Alzheimer disease pathogenesis. Bloom GS JAMA Neurol; 2014 Apr; 71(4):505-8. PubMed ID: 24493463 [TBL] [Abstract][Full Text] [Related]
13. Regulation of Melatonin and Neurotransmission in Alzheimer's Disease. Roy J; Tsui KC; Ng J; Fung ML; Lim LW Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34202125 [TBL] [Abstract][Full Text] [Related]
14. Fibrillar amyloid-beta affects neurofibrillary changes but only in neurons already involved in neurofibrillary degeneration. Wegiel J; Bobinski M; Tarnawski M; Dziewiatkowski J; Popovitch E; Miller DC; Wisniewski T; Golomb J; de Leon MJ; Reisberg B Acta Neuropathol; 2001 Jun; 101(6):585-90. PubMed ID: 11515787 [TBL] [Abstract][Full Text] [Related]
15. [The pathophysiology of Alzheimer's disease with special reference to "amyloid cascade hypothesis"]. Tamaoka A Rinsho Byori; 2013 Nov; 61(11):1060-9. PubMed ID: 24450113 [TBL] [Abstract][Full Text] [Related]
17. Power tools for Alzheimer's disease - an electrochemical preamp for Aβ. Zetterberg H; Hammarström P J Neurochem; 2012 Jul; 122(2):231-2. PubMed ID: 22409410 [No Abstract] [Full Text] [Related]
18. Multifaceted Alzheimer's Disease: Building a Roadmap for Advancement of Novel Therapies. Kaur D; Behl T; Sehgal A; Singh S; Sharma N; Bungau S Neurochem Res; 2021 Nov; 46(11):2832-2851. PubMed ID: 34357520 [TBL] [Abstract][Full Text] [Related]
19. A Study of Amyloid-β and Phosphotau in Plaques and Neurons in the Hippocampus of Alzheimer's Disease Patients. Furcila D; DeFelipe J; Alonso-Nanclares L J Alzheimers Dis; 2018; 64(2):417-435. PubMed ID: 29914033 [TBL] [Abstract][Full Text] [Related]